Pfizer (PFE)

$50.91 0.17 (0.33%)

19:00 EST PFE Stock Quote Delayed 30 Minutes

7 Most Undervalued Stocks to Buy Now

By Joel Baglole, InvestorPlace Contributor Nov 30, 2022

Trust these undervalued stocks to bolster a portfolio once the market reaches a firm bottom and reverses higher for good.

7 Seriously Undervalued Dividend Stocks to Buy for High Total Returns

7 Undervalued Biotech Stocks to Buy Before They Boom

7 Cheap Large-Cap Stocks to Buy Before They Surge Higher

More Articles

Volume:

Previous Close -

Market Cap 285.44B

PE Ratio 9.81

EPS 5.19

Volume (Avg. Vol.) 16.88M

Day's Range $50.48 - $51.33

52-Week Range $41.45 - $61.71

Dividend & Yield $1.56 (3.06%)

PFE Stock Predictions, Articles, and Pfizer News

From InvestorPlace
From the Web

7 Stocks to Buy for the Upcoming Santa Claus Rally

By Josh Enomoto, InvestorPlace Contributor Nov 28, 2022

With experts anticipating a particularly strong Santa Claus rally this year, these are the potential beneficiaries among stocks to buy.

PFE Stock Could Be the Booster Shot Your Portfolio Needs Now

By Louis Navellier and the InvestorPlace Research Staff Nov 23, 2022

PFE stock still remains a dirt-cheap dividend darling, even after across-the-board earnings beats and lifted guidance.

7 Cheap Retirement Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor Nov 14, 2022

With the market imposing some red ink on most companies, now may be an ideal time to consider cheap retirement stocks to buy.

The 7 Most Undervalued Value Stocks to Buy Now

By Alex Sirois Nov 12, 2022

The search for undervalued value stocks has become more difficult, but there is still value to be found if you know where to look.

7 Stocks for Investors Over 30 to Buy and Hold

By Faisal Humayun, InvestorPlace Contributor Nov 11, 2022

What are the best stocks for investors over 30 to buy and hold? Companies with sustained growth prospects along with dividend visibility.

3 Reasons Why It’s a Good Time to Buy PFE Stock

By Louis Navellier and the InvestorPlace Research Staff Nov 11, 2022

With a low valuation, and dividend/earnings growth potential, you may want to consider PFE stock now, before the market starts to catch onto its long-term potential.

The 7 Best Pharma Stocks to Buy Now

By Joel Baglole, InvestorPlace Contributor Nov 8, 2022

Oil and natural gas stocks are not the only ones to post big gains this year. Several pharmaceutical stocks have rallied 30% or more as sales of their blockbuster medications, including Covid-19 vaccines, supercharge their earnings.

7 Stocks to Buy With Stacks of Free Cash Flow

By Louis Navellier and the InvestorPlace Research Staff Nov 7, 2022

Use the Portfolio Grader to find stocks to buy that have plenty of free cash flow and can easily afford to fund dividends or stock buybacks.

Why Is CanSino Biologics (CASBF) Stock Soaring Today?

By Bret Kenwell, InvestorPlace Contributor Nov 2, 2022

CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines.

PFE Stock Alert: 3 Major Takeaways From Pfizer’s Q3 Earnings

By David Moadel, InvestorPlace Contributor Nov 1, 2022

PFE stock traders are getting a bullish triple-whammy today with Pfizer's bottom-line beat, outlook raise and positive vaccine data.

7 Cash-Rich Dividend Stocks to Buy Now

By Alex Sirois Nov 1, 2022

The list that follows includes cash-rich dividend stocks to buy that are performing well right now, despite broad macro headwinds.

Midterm Elections 2022: 3 Stocks to Avoid Like the Plague for a ‘Blue Wave’

By Dana Blankenhorn, InvestorPlace Contributor Oct 27, 2022

Democratic priorities discourage the growth of oil, cryptocurrency and drug prices.

Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today?

By Bret Kenwell, InvestorPlace Contributor Oct 21, 2022

Vaccine stocks are flying higher on Friday on word that Pfizer will quadruple the price of its Covid-19 vaccine. Will others follow suit?

4 High-Yield Dividend Stocks for Retirees Fighting Raging Inflation

By Faisal Humayun, InvestorPlace Contributor Oct 21, 2022

High-yield dividend stocks for retiree that will help in beating inflation as these stocks also trade at attractive valuations. Companies with healthy free cash flows.

The 7 Most Undervalued Value Stocks to Buy Now

By Alex Sirois Oct 10, 2022

Undervalued value stocks remain available even as investors have pivoted toward low-valuation stocks in a volatile year for markets.

7 Blue-Chip Stocks That Are Too Cheap to Ignore

By Thomas Niel, InvestorPlace Contributor Oct 9, 2022

So, what are the best cheap blue-chip stocks out there today? Consider these seven, each one a high-quality business currently trading at a low valuation.

7 Robinhood Stocks That Are Too Cheap to Ignore

By Josh Enomoto, InvestorPlace Contributor Oct 7, 2022

Although some investors may be quick to dismiss these cheap Robinhood stocks, the open-minded will find plenty of goodies.

7 Most Undervalued Stocks to Buy Now

By Joel Baglole, InvestorPlace Contributor Oct 3, 2022

The market downturn has lowered the prices of some of the best stocks available to investors, creating great, undervalued stocks to buy now.

7 S&P 500 Stocks to Sell Before They Die

By Joel Baglole, InvestorPlace Contributor Oct 2, 2022

Investors should unload these S&P 500 stocks to sell and recognize that their fortunes have taken a dramatic turn for the worse.

7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’

By Chris Lau, InvestorPlace Contributor Sep 27, 2022

Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.

Is Veeva Systems Stock a Buy Now?

From The Motley Fool Dec 3, 2022

The cloud-based customer relationship management company faces a lot of near-term headwinds.

Pfizer to invest over €1.2B to boost manufacturing capacity in Belgium

From Seeking Alpha Dec 2, 2022

Pfizer (PFE) plans to invest more than €1.2B ($1.26B) to expand its manufacturing site in Puurs, Belgium, Reuters reported.The site has been involved in the manufacturing of the...

Vaxxinity says COVID shot outperformed Astra and Sinopharm shots as booster (NASDAQ:VAXX)

From Seeking Alpha Dec 2, 2022

Announcing topline data from a Phase 3 trial, Vaxxinity, Inc

Why Roivant Sciences' Shares Are Up Thursday

From The Motley Fool Dec 1, 2022

The company is collaborating with Pfizer to create a portfolio company to develop an encouraging drug to treat ulcerative colitis.

Pfizer to raise biological drug production with $1.26B investment in Ireland (NYSE:PFE)

From Seeking Alpha Dec 1, 2022

Pfizer (PFE) plans to invest more than €1.2B ($1.26B) in Ireland to build a new facility that will double its biological drug substance manufacturing capacity at the existing...

Moderna Stock: Buy, Sell, or Hold in 2023?

From The Motley Fool Dec 1, 2022

Moderna has reached an important turning point.